Ingredient

Cinchona Calisaya Bark Extract

Cinchona Calisaya Bark Extract is flagged for pregnancy, breastfeeding and trying to conceive. The concern behind the strongest flag is known teratogen and absorbed into the body.

By Team TruvaLast checked

Verdict by profile

Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.

Strongest verdict
Not Recommended
Its verdict for pregnancy, the profile this one is worst in
Profiles flagged
3 of 6
Counting avoid, high risk and medium risk
Irritancy
2 of 5
Higher means more likely to sting or redden
PregnancyAVOID

Cinchona Calisaya Bark Extract and pregnancy

Not Recommended

Cinchona Calisaya Bark Extract is derived from cinchona tree bark and contains quinine alkaloids. While used in cosmetics for its antioxidant and skin-conditioning properties, the quinine content raises significant pregnancy concerns. Quinine is classified as FDA Pregnancy Category C for oral use, with documented risks during pregnancy. According to the FDA and ACOG, oral quinine has been associated with birth defects, auditory nerve damage, and other fetal complications. While topical absorption is lower than oral intake, quinine can still penetrate the skin, especially from leave-on products. The amount of systemic absorption from cosmetic use is uncertain, but given quinine's known teratogenic effects, medical experts recommend a precautionary approach. ACOG and most obstetricians advise pregnant women to avoid products containing quinine or cinchona bark extract. The potential risk to fetal development, particularly to the auditory and visual systems, outweighs any cosmetic benefits. This avoidance applies to all trimesters of pregnancy.

BreastfeedingAVOID

Cinchona Calisaya Bark Extract and breastfeeding

Not Recommended

Cinchona bark extract contains quinine alkaloids that can be absorbed through the skin and enter systemic circulation. Quinine is known to pass into breast milk when taken orally or absorbed systemically. According to the American Academy of Pediatrics and FDA guidance, quinine enters breast milk and can potentially affect breastfed infants. While topical cosmetic use results in lower systemic levels than oral medication, the risk of infant exposure exists, particularly with leave-on products applied to large skin areas. Quinine can cause adverse effects in infants including visual and auditory disturbances. Most pediatricians and dermatologists recommend that breastfeeding women avoid cosmetic products containing cinchona bark extract or quinine as a precautionary measure. The potential risk to the breastfed infant, while lower than with oral quinine, is not negligible given the known transfer to breast milk.

PostpartumSAFE

Cinchona Calisaya Bark Extract and postpartum

Safe to Use

For postpartum women who are not breastfeeding, Cinchona Calisaya Bark Extract can be used with standard precautions. The extract provides antioxidant and anti-inflammatory benefits that may help with postpartum skin concerns. The main considerations are the same as for the general population: potential for allergic reactions and photosensitivity. Sun protection is particularly important when using products containing this extract. Start with patch testing to assess individual tolerance.

Trying to ConceiveAVOID

Cinchona Calisaya Bark Extract and trying to conceive

Not Recommended

Cinchona bark extract contains quinine alkaloids that have documented effects on pregnancy when absorbed systemically. Women who are actively trying to conceive should consider avoiding this ingredient as a precautionary measure, given that pregnancy may occur before it is detected. While topical absorption is lower than oral intake, quinine can accumulate in the body and persist for some time. Most fertility specialists and obstetricians recommend discontinuing quinine-containing products when actively trying to conceive to eliminate any potential risk during early pregnancy when fetal development is most vulnerable to teratogens.

PCOSSAFE

Cinchona Calisaya Bark Extract and PCOS

Safe to Use

Cinchona Calisaya Bark Extract contains antioxidant and anti-inflammatory compounds that may benefit skin prone to inflammation and acne, common concerns for women with PCOS. There is no evidence suggesting that topical use of cinchona bark extract affects hormone levels, insulin sensitivity, or androgen activity. The extract does not interfere with the metabolic or hormonal pathways involved in PCOS. Women with PCOS can use products containing this extract, though standard precautions for photosensitivity and potential irritation should be followed. The anti-inflammatory properties may actually be beneficial for managing PCOS-related skin concerns.

General UseSAFE

Cinchona Calisaya Bark Extract and general use

Safe to Use

Cinchona Calisaya Bark Extract is derived from the bark of the cinchona tree and has been used historically for its medicinal properties. In cosmetics, it functions as an antioxidant, anti-inflammatory, and skin conditioning agent, often appearing in anti-aging and toning products. For the general population, the main concerns are photosensitivity and potential for allergic contact dermatitis. The quinine alkaloids in the extract can make skin more sensitive to sun exposure, increasing the risk of sunburn and pigmentation. Some individuals may experience allergic reactions or skin irritation. Users should always wear broad-spectrum sunscreen when using products containing this extract. The cosmetic concentrations of cinchona bark extract are regulated to ensure quinine levels remain within safe limits for topical use. When used properly with sun protection and by individuals without quinine sensitivities, the extract can provide beneficial antioxidant and anti-inflammatory effects for the skin.

Same profiles

Everything else flagged for the same profiles

Keep reading

Related ingredients

Ingredients suggested in place of Cinchona Calisaya Bark Extract, each one with its own page here.

Ingredients that raise the same concerns.

Provenance

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on .

One ingredient is the easy case.

A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.

Download on theApp Store